Corvex Management’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Corvex Management’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-40,000	Closed	-$101K	–	44
2023 Q4	$101K	Hold	40,000	–	–	0.01%	31
2023 Q3	$95.6K	Hold	40,000	–	–	0.01%	34
2023 Q2	$92.4K	Hold	40,000	–	–	﹤0.01%	33
2023 Q1	$102K	Hold	40,000	–	–	0.01%	31
2022 Q4	$100K	Sell	40,000 -2,460,000	-98%	-$6.86M	0.01%	29
2022 Q3	$7.25M	Hold	2,500,000	–	–	0.42%	25
2022 Q2	$11.3M	Hold	2,500,000	–	–	0.72%	24
2022 Q1	$20.1M	Hold	2,500,000	–	–	1.27%	18
2021 Q4	$29.1M	Hold	2,500,000	–	–	1.15%	22
2021 Q3	$31M	Buy	+2,500,000	New	+$28.2M	0.96%	27

Corvex Management's SLGC Position: Q1 2024 in Review

Corvex Management sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 40,000 shares — an estimated $101K sold.

Corvex Management first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $31M in Q3 2021. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Corvex Management reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Corvex Management sold 40,000 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $101K.
Corvex Management first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
Corvex Management's SomaLogic, Inc. Class A Common Stock position peaked at $31M in Q3 2021.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Corvex Management's 13F filing for Q1 2024, filed 15 May 2024.